Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5629]

NBL1: A key driver of ovarian cancer metastasis

NBL1: A key driver of ovarian cancer metastasis

Sugary drinks may increase risk of metastasis in advanced colorectal cancer

Sugary drinks may increase risk of metastasis in advanced colorectal cancer

β-catenin/TCF4 is required for DDX17-induced epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma

β-catenin/TCF4 is required for DDX17-induced epithelial-mesenchymal transition and metastasis in hepatocellular...

Research breakthrough offers hope for new colorectal cancer treatments

Research breakthrough offers hope for new colorectal cancer treatments

Scientists identify dual protein targets to weaken pancreatic cancer defences

Scientists identify dual protein targets to weaken pancreatic cancer defences

FDA approves pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection

FDA approves pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection

NRG Oncology PREDICT-RT study completes patient accrual, tests individualised concurrent therapy and radiation for high-risk prostate cancer

NRG Oncology PREDICT-RT study completes patient accrual, tests individualised concurrent therapy and radiation for...

Nuclear receptors as targets in brain cancer therapy

Nuclear receptors as targets in brain cancer therapy

New pathway to treat a rare and aggressive liver cancer: Blocking CNNM4 protein with RNA technology

New pathway to treat a rare and aggressive liver cancer: Blocking CNNM4 protein with RNA technology

Nuclear receptors as targets in brain cancer therapy

Nuclear receptors as targets in brain cancer therapy

More from ecancer